Franklin Covey CAO Granted 855 Shares; Ownership Now 11,507 – Form 4
Franklin Covey Co. (NYSE: FC) – Form 4 filing dated 14 July 2025 Chief Accounting Officer Anthony D. Hatch reported an acquisition of 855 Franklin Covey common shares on 11 July 2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Franklin Covey Co. (NYSE: FC) – Form 4 filing dated 14 July 2025
Chief Accounting Officer Anthony D. Hatch reported an acquisition of 855 Franklin Covey common shares on 11 July 2025. The shares were received at $0.00 per share, indicating a long-term incentive plan (FY25 LTIP) award rather than an open-market purchase. Following the grant, Hatch’s direct beneficial ownership increased to 11,507 shares.
- No derivative securities were reported.
- The award will vest in three tranches in October 2025, 2026 and 2027.
- The filing was submitted by attorney-in-fact Stephanie King.
The transaction modestly increases insider equity alignment but is immaterial to share count or trading volume and does not imply management’s view on valuation.
Positive
- Increase in insider ownership: CAO’s holdings rise to 11,507 shares, signalling ongoing alignment with shareholders.
- Retention incentive: Three-year vesting schedule encourages long-term performance focus.
Negative
- None.
Insights
TL;DR: Small LTIP grant; neutral market impact.
The $0 cost award merely executes the company’s FY25 long-term incentive program. While insider ownership rises ~7.4%, the absolute number—855 shares—represents less than 0.01% of Franklin Covey’s outstanding stock and therefore carries negligible valuation impact. Because no shares were sold, the filing avoids a negative signal, yet does not constitute a bullish open-market purchase. I view it as routine compensation disclosure.
TL;DR: Routine equity grant supports alignment, not material.
The staggered vesting schedule (2025-2027) incentivises retention and performance, consistent with best-practice governance. However, the grant size is modest for a C-suite role and unlikely to influence strategic behaviour alone. No red flags on compliance or filing timeliness were observed. Overall governance impact is limited.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Shares | 855 | $0.00 | $0.00 |
Footnotes (1)
- F1. FY25 LTIP, third vesting Oct 2025, Oct 2026, Oct 2027.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Franklin Covey (FC) disclose on 14 July 2025?
Was the transaction an open-market purchase or a grant?
AI-generated analysis. How Rhea-AI works. Not financial advice.